Skip to main content

Articles

Page 4 of 16

  1. The Problematic Online Gaming Questionnaire (POGQ) is an 18-item self-rated measure designed to assess the degree of problematic online gaming. This study translated the POGQ into Japanese (POGQ-J) and examine...

    Authors: Kazuya Inoue, Kengo Yokomitsu, Tomonari Irie, Makoto Matsuyama and Masanori Tanaka
    Citation: Addiction Science & Clinical Practice 2021 16:69
    Content type: Research Published on:

  2. The COVID-19 pandemic has exerted a significant toll on the lives of people who use opioids (PWUOs). At the same time, more flexible regulations around provision of opioid use disorder (OUD) services have led ...

    Authors: Noa Krawczyk, Adetayo Fawole, Jenny Yang and Babak Tofighi
    Citation: Addiction Science & Clinical Practice 2021 16:68
    Content type: Review Published on:

  3. The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-u...

    Authors: Kim A. Hoffman, Robin Baker, Laura C. Fanucchi, Paula J. Lum, Lynn E. Kunkel, Javier Ponce Terashima, Dennis McCarty, Petra Jacobs and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2021 16:67
    Content type: Research Published on:

  4. The emergency department (ED) offers an important opportunity to identify patients with opioid use disorder (OUD) and initiate treatment. However, post-ED follow-up is challenging, and novel approaches to enha...

    Authors: Kathryn Hawk, Caitlin Malicki, Jeremiah Kinsman, Gail D’Onofrio, Andrew Taylor and Arjun Venkatesh
    Citation: Addiction Science & Clinical Practice 2021 16:66
    Content type: Research Published on:

  5. Few studies have examined links between current alcohol dependence and specific harms among Indigenous Australians. We investigated these associations as well as help seeking for drinking, awareness of local t...

    Authors: Teagan J. Weatherall, James H. Conigrave, Katherine M. Conigrave, Jimmy Perry, Scott Wilson, Robin Room, Tanya Chikritzhs and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2021 16:65
    Content type: Research Published on:

  6. Medications for opioid use disorder such as opioid agonist treatment (OAT, including methadone, buprenorphine) are the gold standard intervention for opioid use disorder (OUD). Persons with OUD have high rates...

    Authors: Travis M. Scott, Julia Arnsten, James Patrick Olsen, Franchesca Arias, Chinazo O. Cunningham and Monica Rivera Mindt
    Citation: Addiction Science & Clinical Practice 2021 16:64
    Content type: Research Published on:

  7. Alcohol is challenging to discuss, and patients may be reluctant to disclose drinking partly because of concern about being judged. This report presents an overview of the development of a medications review i...

    Authors: Jim McCambridge, Karl Atkin, Ranjita Dhital, Brent Foster, Brendan Gough, Mary Madden, Stephanie Morris, Ronan O’Carroll, Margaret Ogden, Anne Van Dongen, Sue White, Cate Whittlesea and Duncan Stewart
    Citation: Addiction Science & Clinical Practice 2021 16:63
    Content type: Methodology Published on:

  8. Opioid-related overdoses and harms have been declared a public health emergency in the United States, highlighting an urgent need to implement evidence-based treatments. Contingency management (CM) is one of t...

    Authors: Sara J. Becker, Cara M. Murphy, Bryan Hartzler, Carla J. Rash, Tim Janssen, Mat Roosa, Lynn M. Madden and Bryan R. Garner
    Citation: Addiction Science & Clinical Practice 2021 16:61
    Content type: Study Protocol Published on:

  9. Methamphetamine/amphetamine use has sharply increased among people with opioid use disorder (OUD). It is therefore important to understand whether and how use of these substances may impact receipt of, and out...

    Authors: Madeline C. Frost, Hannah Lampert, Judith I. Tsui, Matthew D. Iles-Shih and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2021 16:62
    Content type: Review Published on:

  10. Emergency Departments (EDs) are important arenas for the detection of unhealthy substance use. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for unhealthy alcohol use has been used in some E...

    Authors: Ditte Maria Sivertsen, Ulrik Becker, Ove Andersen and Jeanette Wassar Kirk
    Citation: Addiction Science & Clinical Practice 2021 16:60
    Content type: Research Published on:

  11. Urine drug screening (UDS) is commonly used as part of treatment for opioid use disorder (OUD), including treatment with buprenorphine-naloxone for OUD in a primary care setting. Very little is known about th...

    Authors: Halle G. Sobel, Jill S. Warrington, Samuel Francis-Fath, Abigail M. Crocker and Claudia A. Berger
    Citation: Addiction Science & Clinical Practice 2021 16:59
    Content type: Research Published on:

  13. Stimulant use has increased across the US, with concomitant opioid and methamphetamine use doubling between 2011 and 2017. Shifting patterns of polysubstance use have led to rising psychostimulant-involved dea...

    Authors: Mimi Yen Li, George A. Alba, Julian Mitton and Benjamin Bearnot
    Citation: Addiction Science & Clinical Practice 2021 16:57
    Content type: Research Published on:

  14. Nonmedical use of prescription opioids (defined as taking opioid medications for hedonic effects or in a manner other than prescribed) and the use of heroin have emerged in recent years as major public health ...

    Authors: Elizabeth J. D’Amico, Daniel L. Dickerson, Anthony Rodriguez, Ryan A. Brown, David P. Kennedy, Alina I. Palimaru, Carrie Johnson, Rosanna Smart, David J. Klein, Jennifer Parker, Keisha McDonald, Michael J. Woodward and Ninna Gudgell
    Citation: Addiction Science & Clinical Practice 2021 16:56
    Content type: Study Protocol Published on:

  15. Improving access to medication treatment of opioid use disorder (MOUD) is a national priority, yet common modifiable barriers (e.g., limited provider knowledge, negative beliefs about MOUD) often challenge imp...

    Authors: Eric J. Hawkins, Anissa N. Danner, Carol A. Malte, Brittany E. Blanchard, Emily C. Williams, Hildi J. Hagedorn, Adam J. Gordon, Karen Drexler, Jennifer L. Burden, Jennifer Knoeppel, Aline Lott, George G. Sayre, Amanda M. Midboe and Andrew J. Saxon
    Citation: Addiction Science & Clinical Practice 2021 16:55
    Content type: Research Published on:

  16. Findings have been mixed as to whether brief intervention (BI) is appropriate and effective for individuals with more severe alcohol use problems. Motivation to change drinking has been supported as a mechanis...

    Authors: Lindsay R. Meredith, Erica N. Grodin, Mitchell P. Karno, Amanda K. Montoya, James MacKillop, Aaron C. Lim and Lara A. Ray
    Citation: Addiction Science & Clinical Practice 2021 16:54
    Content type: Research Published on:

  17. Opioid use is one of the most critical public health issues as highly potent opioids contribute to rising rates of accidental opioid-related toxicity deaths. This crisis has affected people from all age groups...

    Authors: Kirsten Marchand, Corinne Tallon, Christina Katan, Jill Fairbank, Oonagh Fogarty, Katrina Marie Pellatt, Roxanne Turuba, Steve Mathias and Skye Barbic
    Citation: Addiction Science & Clinical Practice 2021 16:53
    Content type: Study Protocol Published on:

  18. The advent of direct-acting antivirals (DAAs)—a form of hepatitis C (HCV) treatment associated with shorter treatment course and greater efficacy—offers an unprecedented opportunity to eliminate HCV, but only ...

    Authors: Judith I. Tsui, Michael P. Barry, Elizabeth J. Austin, Elsa W. Sweek, Elyse Tung, Ryan N. Hansen, Michael Ninburg, John D. Scott, Sara N. Glick and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2021 16:52
    Content type: Research Published on:

  19. The Veterans Health Administration (VHA) is invested in expanding access to medication treatment for opioid use disorder (MOUD) to save lives. Access varies across VHA facilities and, thus, requires implementa...

    Authors: Allison M. Gustavson, Marie E. Kenny, Jennifer P. Wisdom, Hope A. Salameh, Princess E. Ackland, Adam J. Gordon and Hildi J. Hagedorn
    Citation: Addiction Science & Clinical Practice 2021 16:51
    Content type: Research Published on:

  21. The COVID-19 pandemic has created a crisis in access to addiction treatment. Programs with residential components have been particularly impacted as they try to keep infection from spreading in facilities and ...

    Authors: Kimberly A. Johnson, Carolyn Keough, Holly Hills, Wouter Vermeer, Rebecca Lengnick-Hall, Moira McNulty, Mark McGovern and Hendricks Brown
    Citation: Addiction Science & Clinical Practice 2021 16:49
    Content type: Commentary Published on:

  22. Smoking is more prevalent and persistent among lower socio-economic status (SES) compared with higher-SES groups, and contributes greatly to SES-based health inequities. Few interventions exist that effectivel...

    Authors: Eline Meijer, Janneke S. Korst, Kristiene G. Oosting, Eline Heemskerk, Sander Hermsen, Marc C. Willemsen, Bas van den Putte, Niels H. Chavannes and Jamie Brown
    Citation: Addiction Science & Clinical Practice 2021 16:48
    Content type: Research Published on:

  24. Little is known about prevalence and treatment of OUD among youth engaged in primary care (PC). Medications are the recommended treatment of opioid use disorder (OUD) for adolescents and young adults (youth). ...

    Authors: Sarah M. Bagley, Laura Chavez, Jordan M. Braciszewski, Mary Akolsile, Denise M. Boudreau, Gwen Lapham, Cynthia I. Campbell, Gavin Bart, Bobbi Jo H. Yarborough, Jeffrey H. Samet, Andrew J. Saxon, Rebecca C. Rossom, Ingrid A. Binswanger, Mark T. Murphy, Joseph E. Glass and Katharine A. Bradley
    Citation: Addiction Science & Clinical Practice 2021 16:46
    Content type: Research Published on:

  25. Office-Based Opioid Treatment (OBOT) is a delivery model which seeks to make medications for opioid use disorder (MOUD), particularly buprenorphine, widely available in general medical clinics and offices. Des...

    Authors: Dominic Hodgkin, Constance Horgan and Gavin Bart
    Citation: Addiction Science & Clinical Practice 2021 16:45
    Content type: Review Published on:

  26. Support from family and other social network elements can be important in helping patients to cope with practical and emotional consequences of diseases. The aim of the study was to examine perception of famil...

    Authors: Bente Birkeland, Bente Weimand, Torleif Ruud, Darryl Maybery and John-Kåre Vederhus
    Citation: Addiction Science & Clinical Practice 2021 16:44
    Content type: Research Published on:

  27. Compared to smokers with favorable socio-economic position (SEP), those with low SEP are less likely to have a successful smoking cessation attempt. Tailored approaches are therefore needed, and general practi...

    Authors: Mégane Héron, Anne-Laurence Le Faou, Gladys Ibanez, Brigitte Métadieu, Maria Melchior and Fabienne El-Khoury Lesueur
    Citation: Addiction Science & Clinical Practice 2021 16:43
    Content type: Research Published on:

  28. Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone tre...

    Authors: Kerry Marshall, Geoffrey Maina and Jordan Sherstobitoff
    Citation: Addiction Science & Clinical Practice 2021 16:42
    Content type: Research Published on:

  29. There is no longer support for the idea that brief intervention programmes alone can contribute meaningfully to the improvement of population health relating to alcohol. As a result, calls for major innovation...

    Authors: Jim McCambridge
    Citation: Addiction Science & Clinical Practice 2021 16:41
    Content type: Commentary Published on:

    The Correction to this article has been published in Addiction Science & Clinical Practice 2021 16:58

  30. Opioid use disorder (OUD) disproportionately impacts rural and American Indian communities and has quadrupled among pregnant individuals nationwide in the past two decades. Yet, limited data are available abou...

    Authors: A. Taylor Kelley, Marcela C. Smid, Jacob D. Baylis, Elizabeth Charron, Amy E. Binns-Calvey, Shayla Archer, Saul J. Weiner, Lori Jo Begaye and Gerald Cochran
    Citation: Addiction Science & Clinical Practice 2021 16:40
    Content type: Study Protocol Published on:

  31. Because of the shortage of health professionals in Chilean primary care, Health Technicians (HT) are providing Brief Interventions (BI) for risky alcohol consumption. We compared the efficacy of two AUDIT-link...

    Authors: Nicolas A. Barticevic, Fernando Poblete, Soledad M. Zuzulich, Victoria Rodriguez, Diego Quevedo, Brena F. Sena and Laura Bradshaw
    Citation: Addiction Science & Clinical Practice 2021 16:39
    Content type: Research Published on:

  32. Measurement-based care (MBC) is the practice of routinely administering standardized measures to support clinical decision-making and monitor treatment progress. Despite evidence of its effectiveness, MBC is r...

    Authors: Justin S. Tauscher, Eliza B. Cohn, Tascha R. Johnson, Kaylie D. Diteman, Richard K. Ries, David C. Atkins and Kevin A. Hallgren
    Citation: Addiction Science & Clinical Practice 2021 16:38
    Content type: Research Published on:

  33. Most Americans with opioid use disorder (OUD) do not receive indicated medical care. A clinical decision support (CDS) tool for primary care providers (PCPs) could address this treatment gap. Our primary objec...

    Authors: Rebecca C. Rossom, JoAnn M. Sperl-Hillen, Patrick J. O’Connor, A. Lauren Crain, Laurel Nightingale, Anne Pylkas, Kristen V. Huntley and Gavin Bart
    Citation: Addiction Science & Clinical Practice 2021 16:37
    Content type: Research Published on:

  34. Opioid withdrawal symptoms prior to buprenorphine initiation may be intolerable and as a result, alternative strategies have emerged. We aim to systematically review the efficacy and safety of buprenorphine in...

    Authors: K. K. Adams, M. Machnicz and D. M. Sobieraj
    Citation: Addiction Science & Clinical Practice 2021 16:36
    Content type: Review Published on:

  35. Gambling-related harm is an increasing recognised problem internationally. Recent years have seen an explosion in opportunities to gamble, both in person and online. Health and other care settings have the pot...

    Authors: Lindsay Blank, Susan Baxter, Helen Buckley Woods and Elizabeth Goyder
    Citation: Addiction Science & Clinical Practice 2021 16:35
    Content type: Research Published on:

  37. Successfully combating the opioid crisis requires patients who misuse opioids to have access to affirming and effective health care. However, there is a shortage of physicians who are willing to work with thes...

    Authors: Berkeley Franz, Lindsay Y. Dhanani and Daniel L. Brook
    Citation: Addiction Science & Clinical Practice 2021 16:33
    Content type: Research Published on:

  38. Youth are frequently exposed to drugs, and most youth who misuse drugs are reluctant to seek help from services due to the worry of others being judgmental, lacking expertise, exposing their personal informati...

    Authors: William Ho Cheung Li, Wei Xia, Laurie Long Kwan Ho, Ankie Tan Cheung, Queenie Kuai I. Leong and Tingna Liang
    Citation: Addiction Science & Clinical Practice 2021 16:32
    Content type: Study Protocol Published on:

  39. Screening, brief intervention and referral to treatment (SBIRT) programmes have resulted in generally positive outcomes in healthcare settings, particularly for problem alcohol use, yet implementation is hampe...

    Authors: Claire van der Westhuizen, Megan Malan, Tracey Naledi, Marinda Roelofse, Bronwyn Myers, Dan J. Stein, Sa’ad Lahri and Katherine Sorsdahl
    Citation: Addiction Science & Clinical Practice 2021 16:31
    Content type: Research Published on:

  40. Homeless youth experience high rates of substance use disorders, exposures to violence, mental and physical health conditions, and mortality. They have been particularly affected by the opioid crisis. However,...

    Authors: Natasha Slesnick, Laura Chavez, Alicia Bunger, Ruri Famelia, Jodi Ford, Xin Feng, Sarah Higgins, Eugene Holowacz, Soren Jaderlund, Ellison Luthy, Allen Mallory, Jared Martin, Laura Walsh, Tansel Yilmazer and Kelly Kelleher
    Citation: Addiction Science & Clinical Practice 2021 16:30
    Content type: Study Protocol Published on:

  41. High comorbidity exists between mental illness and substance use disorders (SUD). Patients in psychiatry living with problematic alcohol or drug consumption can experience a sense of exclusion, where seeking h...

    Authors: Elisabeth Petersén, Anna Thurang and Anne H. Berman
    Citation: Addiction Science & Clinical Practice 2021 16:29
    Content type: Research Published on:

  42. Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a n...

    Authors: Betty Tai, Ronald Dobbins, Quandra Blackeney, David Liu and Landhing Moran
    Citation: Addiction Science & Clinical Practice 2021 16:28
    Content type: Commentary Published on:

  43. South Africa is marked by high rates of both HIV and alcohol use, and there is a detrimental synergistic relationship between these two epidemics. The Institute of Medicine recommends integrated care for alcoh...

    Authors: Caroline C. Kuo, Goodman Sibeko, Morayo Akande, Shaheema Allie, Nurain Tisaker, Dan J. Stein and Sara J. Becker
    Citation: Addiction Science & Clinical Practice 2021 16:27
    Content type: Study Protocol Published on:

  44. While patient-reported treatment dissatisfaction is considered an important factor in determining the success of substance use disorder treatment, the levels of dissatisfaction with opioid agonist therapies (O...

    Authors: Lindsay Mackay, Thomas Kerr, Nadia Fairbairn, Cameron Grant, M.-J. Milloy and Kanna Hayashi
    Citation: Addiction Science & Clinical Practice 2021 16:26
    Content type: Research Published on:

  45. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, Melissa B. Weimer and Zoe M. Weinstein
    Citation: Addiction Science & Clinical Practice 2021 16:25
    Content type: Correction Published on:

    The original article was published in Addiction Science & Clinical Practice 2021 16:13

  46. Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities. With the immediate need for remote...

    Authors: Yih-Ing Hser, Allison J. Ober, Alex R. Dopp, Chunqing Lin, Katie P. Osterhage, Sarah E. Clingan, Larissa J. Mooney, Megan E. Curtis, Lisa A. Marsch, Bethany McLeman, Emily Hichborn, Laurie S. Lester, Laura-Mae Baldwin, Yanping Liu, Petra Jacobs and Andrew J. Saxon
    Citation: Addiction Science & Clinical Practice 2021 16:24
    Content type: Commentary Published on:

  47. Unhealthy alcohol use is a key concern for Aboriginal and Torres Strait Islander (‘Indigenous Australian’) communities. Due to systematic disadvantage and inter-generational trauma, Indigenous Australians may ...

    Authors: James H. Conigrave, Emma L. Bradshaw, Katherine M. Conigrave, Richard M. Ryan, Scott Wilson, Jimmy Perry, Michael F. Doyle and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2021 16:23
    Content type: Research Published on:

  48. Knowledge of medical conditions and their evidence-based medications varies among individuals. This range of knowledge may affect attitudes and influence medical decision-making of both patients and providers....

    Authors: Caroline Shadowen, Rachel Wheeler and Mishka Terplan
    Citation: Addiction Science & Clinical Practice 2021 16:22
    Content type: Research Published on:

  49. The Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) is commonly used in hospitals to titrate medications for alcohol withdrawal syndrome (AWS), but may be difficult to apply to intensive...

    Authors: Tessa L. Steel, Shewit P. Giovanni, Sarah C. Katsandres, Shawn M. Cohen, Kevin B. Stephenson, Ben Murray, Hillary Sobeck, Catherine L. Hough, Katharine A. Bradley and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2021 16:21
    Content type: Letter to the Editor Published on:

  50. Chronic pain and heavy drinking are conditions that commonly co-occur among primary care patients. Despite the availability of behavioral interventions that target these conditions individually, engagement and...

    Authors: Tibor P. Palfai, Maya P. L. Kratzer, Natalia E. Morone and Judith A. Bernstein
    Citation: Addiction Science & Clinical Practice 2021 16:20
    Content type: Research Published on:
Submit manuscript

Follow

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    4.4 - 5-year Impact Factor
    0.956 - SNIP (Source Normalized Impact per Paper)
    1.166 - SJR (SCImago Journal Rank)

    2022 Speed
    17 days submission to first editorial decision for all manuscripts (Median)
    193 days submission to accept (Median)

    2022 Usage 
    679,436 downloads
    1,570 Altmetric mentions 

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.

Addiction Science & Clinical Practice

ISSN: 1940-0640